AB0789 How does the duration of the disease influence the quality of life?. (12th June 2018)
- Record Type:
- Journal Article
- Title:
- AB0789 How does the duration of the disease influence the quality of life?. (12th June 2018)
- Main Title:
- AB0789 How does the duration of the disease influence the quality of life?
- Authors:
- Loghin-Oprea, N.
Vetrila, S.
Mazur-Nicorici, L.
Salaru, V.
Mazur, M. - Abstract:
- Abstract : Background: It is noticed that over the last decades the prognostic in patients with Idiopathic Inflammatory Myopathies (IIM) – a group of autoimmune disease characterised by muscle involvement, has improved along with increasement of disease duration and thus affects the quality of life. Objectives: To assess the patient's quality of life related to the duration of the disease. Methods: We performed a cross-sectional study from December 2015 to December 2017, the patients included fulfilled the Bohan and Peter 1 criteria for IIM. Demographic and clinical data were collected using a special questionnaire. Consistent with the objective the study group was divided in two subgroups by disease duration 1-less than 24 months and second subgroup maore than 2 years. In order to estimate the quality of life (QoL) was applied Short Form-8 with 8 items for 8 domains and two components: mental and physical. Statistical data was analysed using MedCalc software version 12. Results: There were 67 patients enrolled in the study, including 51 females and 16 males with a F:M ratio of 3.2:1, mean age 53.1±12.5 (range 25–78). The disease mean disease duration was 8.3±5.3 (range 0.5–12) years, there were 16 patients in the subgroup with the disease duration less than 2 years. The mean physical component was 36.48±9.05 and the mental component – 41.69±9.62 points, determined as reduced quality of life. Regarding the QoL of patients from subgroup 1, we found the physical component –Abstract : Background: It is noticed that over the last decades the prognostic in patients with Idiopathic Inflammatory Myopathies (IIM) – a group of autoimmune disease characterised by muscle involvement, has improved along with increasement of disease duration and thus affects the quality of life. Objectives: To assess the patient's quality of life related to the duration of the disease. Methods: We performed a cross-sectional study from December 2015 to December 2017, the patients included fulfilled the Bohan and Peter 1 criteria for IIM. Demographic and clinical data were collected using a special questionnaire. Consistent with the objective the study group was divided in two subgroups by disease duration 1-less than 24 months and second subgroup maore than 2 years. In order to estimate the quality of life (QoL) was applied Short Form-8 with 8 items for 8 domains and two components: mental and physical. Statistical data was analysed using MedCalc software version 12. Results: There were 67 patients enrolled in the study, including 51 females and 16 males with a F:M ratio of 3.2:1, mean age 53.1±12.5 (range 25–78). The disease mean disease duration was 8.3±5.3 (range 0.5–12) years, there were 16 patients in the subgroup with the disease duration less than 2 years. The mean physical component was 36.48±9.05 and the mental component – 41.69±9.62 points, determined as reduced quality of life. Regarding the QoL of patients from subgroup 1, we found the physical component – 38.15±8.83 and the mental was 40.95±9.22 points. In the second subgroup we appreciated the physical and the mental component – 35.77±9.14 and 42.01±9.86 points, respectively. It was identified moderate correlation (r=0.49 p<0.005) between the both domains of the QoL and disease duration till 2 years, for the duration of more than 2 years we found moderate correlation (r=0.51 p<0.005) with mental compound and a weak one for physical domain (r=0.24 p<0.005). Conclusions: Patients with idiopathic inflammatory myopathies had reduced quality of life by both domains. Disease duration in patients with early idiopathic inflammatory myopathies – less than 2 years, has a greater impact on patient's quality of life. Reference: [1] Bohan A, Peter JB. N Engl J Med1975Feb 13;292(7):344–7. Disclosure of Interest: None declared … (more)
- Is Part Of:
- Annals of the rheumatic diseases. Volume 77(2018)Supplement 2
- Journal:
- Annals of the rheumatic diseases
- Issue:
- Volume 77(2018)Supplement 2
- Issue Display:
- Volume 77, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 77
- Issue:
- 2
- Issue Sort Value:
- 2018-0077-0002-0000
- Page Start:
- 1528
- Page End:
- 1528
- Publication Date:
- 2018-06-12
- Subjects:
- Rheumatism -- Periodicals
616.723005 - Journal URLs:
- http://ard.bmjjournals.com/ ↗
http://www.pubmedcentral.nih.gov/tocrender.fcgi?journal=149&action=archive ↗
http://www.bmj.com/archive ↗
http://gateway.ovid.com/server3/ovidweb.cgi?T=JS&MODE=ovid&D=ovft&PAGE=titles&SEARCH=annals+of+the+rheumatic+diseases.tj&NEWS=N ↗ - DOI:
- 10.1136/annrheumdis-2018-eular.5450 ↗
- Languages:
- English
- ISSNs:
- 0003-4967
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20154.xml